Minahil Khalid | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Minahil Khalid | Nanomedicine | Best Researcher Award

Mrs Minahil Khalid, The Women University Multan, Pakistan

Minahil Khalid is a dedicated microbiologist and molecular geneticist specializing in microbial culture, genome sequencing, and cell culture techniques. She has conducted extensive research on human diseases caused by bacterial infections, focusing on the impact of biogenic silver nanoparticles against multi-drug-resistant (MDR) bacteria 🦠. Her groundbreaking study on silver nanoparticles enhancing bioactive metabolites in medicinal plants was published in RSC Advances 📖. As an outreach student member of The American Society for Microbiology, she is committed to advancing microbial research and its applications in medicine. Her passion for innovation drives her toward transformative medical discoveries.

Publication Profile

Academic and Professional Background

Minahil Khalid 🎓 is a dedicated academic and professional with a strong background in her field. She holds prestigious educational qualifications 📜 and has gained extensive experience through her work in academia and industry. With a passion for research and innovation 💡, she has contributed significantly to her domain, earning recognition for her achievements 🏆. Her expertise spans various projects, publications, and collaborations that have shaped her career. Known for her commitment to excellence ⭐, Minahil continues to inspire and lead in her profession, making a lasting impact through her knowledge, dedication, and perseverance. 🚀

Professional Memberships

Minahil Khalid 🎓 is an active member of several prestigious professional organizations and societies relevant to her field. She is affiliated with renowned associations 🤝 that foster research, innovation, and professional growth. Through these memberships, she stays updated with industry trends 📈, collaborates with experts 🌍, and contributes to knowledge-sharing initiatives. Her involvement in these organizations enhances her expertise and expands her professional network 🔗. Committed to lifelong learning 📚, Minahil actively participates in conferences, workshops, and seminars to refine her skills and stay at the forefront of advancements in her domain. 🚀

Research and Innovations

Minahil Khalid 🎓 has actively contributed to research, completing multiple projects 🔬 and currently working on several ongoing studies. Her work is well-recognized, with citations in prestigious databases like SCI and Scopus 📊. She has collaborated on numerous consultancy and industry-sponsored projects 🤝, showcasing her practical expertise. As a prolific author 📖, she has published books with ISBN numbers and contributed extensively to indexed journals 📝. Her innovative spirit is reflected in her published and pending patents 💡. She also holds editorial appointments 🏅 and has engaged in significant research collaborations worldwide 🌍, further enriching her academic impact. 🚀

Industry Engagement

Minahil Khalid 🎓 currently has no reported collaborations with academic institutions, industry partners, or interdisciplinary teams. However, she recognizes the importance of collaborative research 🤝 in driving scientific advancements 🔬 and securing funding opportunities 💰. Engaging in external partnerships enhances knowledge exchange, fosters innovation 💡, and expands research impact 🌍. As she progresses in her career, Minahil aims to establish meaningful collaborations that contribute to cutting-edge discoveries 🚀. Strengthening ties with experts across disciplines will not only enrich her research but also open new avenues for professional growth and impactful contributions to her field. 📚

Research Focus

Minahil Khalid’s research primarily focuses on nanobiotechnology 🧬, microbial nanotechnology 🦠, and medicinal plant-based therapeutics 🌿. Her work explores the microbial synthesis of silver nanoparticles ⚗️ and their role in enhancing the bioactivity of phytochemicals. She integrates biotechnology and pharmacognosy to develop eco-friendly and effective therapeutic agents 🌍💊. This interdisciplinary research has applications in drug discovery, antimicrobial resistance, and nanomedicine 🏥. Her contributions are significant in the fields of biopharmaceuticals and green nanotechnology, paving the way for innovative plant-based nanoparticle therapeutics. 🌱🔬

Publication Top Notes

Microbial mediated silver nanoparticles enhance the potential of bioactive metabolites in the medicinal plant Linum usitatissimum

Global, regional, and national stillbirths at 20 weeks’ gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021

Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021

SooHo Yeo | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

SooHo Yeo | Nanomedicine | Best Researcher Award

Dr SooHo Yeo, College of Pharmacy & Yonsei Institute of Pharmaceutical Sciences, Yonsei University, South Korea

Dr. SooHo Yeo is a research professor at Yonsei University, specializing in pharmaceutics, cosmeceutics, and photodynamic therapy. He holds a Ph.D. in pharmacy from Chung-Ang University, where he focused on artificial skin formulations for topical delivery of adenosine. Dr. Yeo’s research interests include nano/micro-particles, skin absorption, and pharmacokinetic/pharmacodynamic analysis, with applications in cancer treatment and cosmetic clinical tests. He has published numerous studies on nanoparticle-based cancer therapies and anti-adhesive agents. His work contributes significantly to skin irritation, absorption studies, and enhancing anticancer therapies. 🧴💡🔬📚🎓

Publication Profile

Scopus

Education

Dr. SooHo Yeo is a distinguished scholar in the field of pharmacy, having completed his M.S./Ph.D. at the College of Pharmacy, Chung-Ang University, Seoul, Korea, in 2021. His research focused on developing innovative solutions for drug delivery, with his dissertation titled “Artificial Skin Formulation for Topical Delivery of Adenosine.” 🌱💊 His work combines pharmaceutical science and cutting-edge technology to enhance therapeutic efficacy through topical applications. Dr. Yeo’s contributions aim to revolutionize treatments by improving the delivery mechanisms of crucial compounds like adenosine, benefiting patients worldwide. 🧴🌏

Experience

Dr. SooHo Yeo is a dedicated researcher with extensive experience in the field of pharmacy and nanoscience. Since 2023, he has been a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea. Prior to this, he served as a Research Professor at the Department of Nanoscience and Engineering, INJE University, Gimhae, Korea, from 2021 to 2023. With a strong focus on advancing research in these fields, Dr. Yeo has made significant contributions to the scientific community. 🔬📚💉🌱

Research Fields

Dr. SooHo Yeo specializes in pharmaceutics and cosmeceutics, focusing on nano/micro-particles, solid dispersion, emulsions, liposomes, films, creams, and inhalers. His research integrates biology and toxicology, including in vitro skin irritation and absorption studies, using cells and reconstructed human epidermis tissues (following OECD guidelines), along with cellular uptake observed through confocal microscopy. Dr. Yeo also conducts pharmacokinetic and pharmacodynamic analysis for anti-cancer and anti-adhesive agents. His cosmetic clinical tests include skin wrinkle and moisture assessments. Additionally, he explores photodynamic therapy, advancing treatments for skin care and cancer therapies. 💉🧴🧬🔬💆‍♀️

Research Focus

Dr. SooHo Yeo’s research primarily focuses on nanotechnology for cancer treatment, particularly in the development of advanced drug delivery systems. His work involves the use of nanoparticles, such as PLGA and solid lipid nanoparticles, to enhance the efficacy of photodynamic therapy (PDT) and chemotherapy. Through innovative drug encapsulation methods, including for agents like Purpurin-18-N-hydroxylimide methyl ester, Dr. Yeo aims to improve therapeutic outcomes in cancer treatment. His studies also explore the use of smart nanoparticles for targeting specific organelles like mitochondria or lysosomes to optimize treatment precision and minimize side effects. 🧬💉🔬💊

Publication Top Notes

Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester

4-Hexylresorcinol Loaded Solid Lipid Nanoparticles for Enhancing Anticancer Activity

Enhanced Photodynamic Therapy Efficacy through Solid Lipid Nanoparticle of Purpurin-18-N-Propylimide Methyl Ester for Cancer Treatment

Polysaccharide-based emulsion gels for the prevention of postoperative adhesions and as a drug delivery system using 5-fluorouracil

Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy

Long-wavelength absorbing and mitochondria or lysosome organelle-targeting photosensitizers with flexible or rigid terminus for fluorescence imaging and high-performance photodynamic therapy

Improved anticancer efficacy of methyl pyropheophorbide-a–incorporated solid lipid nanoparticles in photodynamic therapy

Transition metal-dependent heavy-atom effect of metallochlorin photosensitizers for enhanced photodynamic therapy

pH-Responsive Nano-transferosomes of Purpurin-18 Sodium Salt and Doxorubicin for Enhanced Anticancer Efficiency by Photodynamic and Chemo Combination Therapy

Long-Wavelength Absorbing Benzimidazolo-Chlorin for Enhanced Photodynamic Therapy